鼻敏康颗粒治疗变应性鼻炎98例临床疗效观察

Clinical observation of Biminkang granules in treating allergic rhinitis

目的:观察鼻敏康颗粒治疗变应性鼻炎的临床疗效。方法:选取2013年-2014年耳鼻喉科门诊收治的变应性鼻炎患者98例,随机分为治疗组和对照组,每组49例。治疗组服用鼻敏康颗粒,对照组服用氯雷他定片。比较两组病例的近期和远期治疗效果。结果:两组病例服药结束后第1天对照组总有效率93.88%,治疗组总有效率91.84%,治疗后两组病例近期总有效率比较差异无统计学意义(P>0.05);两组病例服药结束后第15天对照组总有效率69.39%,治疗组总有效率83.67%,两组远期总有效率比较差异有统计学意义(P<0.05)。结论:鼻敏康颗粒和氯雷他定片对变应性鼻炎均有一定疗效,但鼻敏康颗粒远期疗效较氯雷他定片更突出,值得临床推广。

Objective：To investigate the clinical effect of Biminkang granule in treating allergic rhinitis. Methods：98 cases were randomly divided into treatment group and control group,each of 49 cases. The patients in treatment group were treated with Biminkang granules,patients in control group were treated with Loratadine tablets. The short-term and long-term therapeutic effects were observed of two groups. Results：The short-term total effective rate of treatment group was 91.84% and the control group was 93.88%. There was no statistical significance between them（P〉0.05）. The long-term total effective rate of treatment group was higher than that of control group（P〈0.05）. Conclusion：Biminkang granules and Loratadine tablets are effective to allergic rhinitis,and long-term efficacy of Biminkang granule is better than that of Loratadine tablets.It is worth clinical promotion.